Institute of Hematology & Blood Diseases Hospital
Institute of Hematology & Blood Diseases Hospital
Tianjin, China1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| CAR T-cell Therapy Targeting CD19 and BCMA(QT-019C) in Patients With Relapse/Refractory Autoimmune Diseases | Skin and Connective Tissue Diseases, anti-neutrophil cytoplasmic antibody-associated vasculitis, autoimmune disease, cardiovascular disorder, connective tissue disorder, immune system disorder, necrotizing vasculitis, skin disorder, skin vascular disease, systemic lupus erythematosus, vascular disorder, vasculitis | Recruiting | Phase 1 | 2026-01-20 | NCT07315087 |